Back to VANGUARD GROUP INC VANGUARD GROUP INC

KROSKROS
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in KEROS THERAPEUTICS INC

VANGUARD GROUP INC holds 1.5M shares of KROS (KEROS THERAPEUTICS INC), worth $31.1M as of 2025-Q4. The position was decreased (-43.9% shares). KROS represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$31.1M

Current Shares

1.5M

Total Value Change

-$76.7M

Total Shares Change

-331,063

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
1.5M
-43.9%
$31.1M0.0%$20.27
0
2025-Q3
Increased
2.7M
+3.3%
$43M0.0%$15.95
30
2025-Q2
Increased
2.6M
+2.5%
$35.1M0.0%$13.49
30
2025-Q1
Increased
2.6M
+31.1%
$26.2M0.0%$10.79
36
2024-Q4
Increased
2M
+5.4%
$31M0.0%$15.64
30
2024-Q3
New
1.9M
-
$107.8M0.0%$56.45
42

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used